Accumulation: What It Means and How to Calculate It
Watch our on demand webinar to discover fast, flexible, frictionless PK/PD workflows with Phoenix Cloud.…
CertaraApril 2, 2025
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
RADNOR, PA — April 1st, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraApril 1, 2025
How to Make 3rd Party Reconciliation in Clinical Data Management More Efficient
Learn how to streamline 3rd party reconciliation in clinical data management with reusable standards, centralized…
CertaraMarch 31, 2025
MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants
Explore how model-informed drug development (MIDD) enhanced clinical lactation studies and supported global health policy…
CertaraMarch 28, 2025
Building effective health economic models: key components for success
March 28, 2025 Editor’s note: This is the first in a series of four articles…
CertaraMarch 28, 2025
Mechanistic Modeling Guides Bispecific Antibody Design and Target Selection for Maximizing Therapeutic Window
Therapeutic antibodies have shown promise in treating diseases such as cancer, but selectivity remains a…
CertaraMarch 28, 2025
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Certara’s Steve Sibley, Vice President Regulatory Strategy, is quoted in this Pharma's Almanac article about…
CertaraMarch 28, 2025
BaseCase Community Meetup 2025 – Session Recordings
Certara: Transforming Drug Development for Good Martin Snyder Basecase 2025 and Beyond: Preparing for Tomorrow’s…
CertaraMarch 28, 2025
The Revolution of Metadata Standardization with Clinical Metadata Repository (CMDR)
Solution Consultant, Software, APAC (Japan) Rico Fujita is a Software Solution Consultant in Japan, APAC.…
CertaraMarch 27, 2025
